Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 30, 2015
Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer CellsQingfeng Hu, Shijun Tong, Xiaojun Zhao, et al.
Journal of the American Chemical Society|July 21, 2026
Frozen-State Electrochemistry Enables Proton-Selective Reaction Environments for Deterministic Atomic ConstructionXue Zhou, Shijun Tong, Zhiquan An, et al.
Science Progress|March 24, 2026
Development and validation of an online machine-learning tool for predicting delirium risk in older adults with type 2 diabetes: A retrospective cohort study based on the MIMIC-IV databaseLang Gao, Guangdong Wang, Xingyi Yang, et al.
Molecules (Basel, Switzerland)|September 14, 2024
Probing the Effect of Alloying Elements on the Interfacial Segregation Behavior and Electronic Properties of Mg/Ti Interface via First-Principles CalculationsYunxuan Zhou, Hao Lv, Tao Chen, et al.
Cancer Epidemiology|March 18, 2014
Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?Weihong Ding, Zhongqing Chen, Yuancheng Gou, et al.
Medicine|April 9, 2021
The relationship between nutritional status and the prognosis of COVID-19: A retrospective analysis of 63 patientsYuhong Li, Shijun Tong, Xueyuan Hu, et al.
Plos One|November 29, 2012
Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011Rong Na, Haowen Jiang, Seong-Tae Kim, et al.
Proteome Science|April 21, 2011
Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsyChuanyu Sun, Chao Song, Zhicheng Ma, et al.
World Journal of Urology|April 21, 2015
Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groupsWeihong Ding, Shijun Tong, Yuancheng Gou, et al.
Plos One|October 20, 2012
The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancerZhongqing Chen, Weihong Ding, Ke Xu, et al.
Pageof 3